Excelling with care

We deliver quality and agility for your research project, throughout Europe.

Discuss your project

Leadership Appointments

Excelya appoints Nathalie Doize as Director of Operations and Rudolph Rosenberg as CFO

Read the press release

All things eTMF

Petek Berker Birik, a Day in the Life

Read the article
We deliver quality and agility for your research project, throughout Europe.
Excelya appoints Nathalie Doize as Director of Operations and Rudolph Rosenberg as CFO
Petek Berker Birik, a Day in the Life
Clarity initiative efficiency

A unique full-service CRO model

Excelya stands apart from all other clinical development companies working for healthcare businesses. We are the only independent European CRO providing R&D players with full-service offers within a cooperative framework. Our clients can depend on the highest degree of involvement to guarantee the excellence they need.

Our customized solutions perfectly match the scope and specificity of our clients’ research projects.

Our approach is centred on understanding our clients’ needs and a capacity for initiative driven by efficiency, in addition to perfect operational, scientific and regulatory precision. We actively cultivate this professional and human mindset within our 800 strong team force. Our team members are trained to invest their work with their best in personality and commitment.

They embody our two fundamental values : the ambition of excellence and team enterprising.

0+
Excelyates
0
Countries
0+
Studies
Different types of partnership to meet your needs

Our solutions

Excelya is a Contract Research Organization (CRO), providing support to clients around the globe in the pharmaceutical, medical device and biotechnology industries. Founded with a strong desire to add value and to deliver expertise to both clients and employees alike, Excelya strive to become an integrated part of sponsor teams and projects, while also nurturing and developing team members over the long term. By delivering long term career development to staff, we are able to provide clients with contractors who are dedicated and are rich in expertise and experience. 

To meet your needs, we leverage 30 years of local, therapeutic and service experience. Our focus is on your project utilizing our expertise, experience and technology. 

Our aim is to expertly recruit the right profiles and implement the right processes to help our clients meet their objectives. Not only do we have an impressive existing network of employees across Europe and beyond, but regularly attract and onboard high-quality candidates. We believe that our people are our greatest assets, and have an internal team dedicated to sourcing, recruiting, and nurturing our best-in-class team members.

Not only do Excelya supply quality people to execute your clinical trials and R&D operations, we also have a uniquely scalable model where clients receive a tailored SLA which will deliver the results needed, in a way that satisfies a plethora of budgets, geographies, trial phases, therapeutic areas and more. 

Talent management and project management are our core products, which we are able to deliver expertly across an array of different therapeutic areas. We operate in either a Full Service, Functional Service Provider or Consulting framework, reflecting multiple operational capabilities. 

Our tripartite solution model allows us to offer clients a highly customized service level and experience. We do not offer fixed packages, and no Excelya project looks the same. They are always tailored and are as unique as the drug and medical device development companies we partner with. We are able to scale our influence and involvement in any clinical trial, according to client requirements. 

Excelya has also been awarded a silver EcoVadis sustainability rating in 2021, meaning that they have demonstrated consistent high standards and good practices in the areas of Environment, Labor & Human Rights, Ethics and Sustainable Procurement, with ambitions to improve this even further in the near future.

Excelya is proud to be the highest quality European CRO, with the most comprehensive service coverage throughout Europe. With a superb, highly qualified, experienced and dedicated team who pride themselves on offering a high value service to our clients, we are confident that a partnership with Excelya will ensure that your R&D clinical trials go smoothly. 

 

Understanding, initiative and commitment

Our therapeutic areas

Our approach is centred on understanding our clients’ needs and a capacity for initiative driven by efficiency, in addition to perfect operational, scientific and regulatory precision. Our team members are trained to invest their work with their best in personality and commitment.

Our wealth of expertise and scope of knowledge allows us to offer attractive packages to clients, often spanning across multiple therapeutic areas.

We operate with the same degree of involvement and aspiration for excellence in today’s most important therapeutic areas, medical devices and emerging digital health solutions.

The power to change patients’ lives

Join us

Working at Excelya means joining a participatory company in which our team members have the resources to express their natural talents and can leverage the entire spectrum of their personality. This approach can significantly change patients’ lives, both in the broadest fields and the most innovative niche areas.

Publications

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial Spyridon G. Deftereos, MD, PhD; Georgios Giannopoulos, MD, PhD; Dimitrios A. Vrachatis, MD, MSc, PhD;...
Download
Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)—An Old Drug With New Life? Amir B. Rabbani, MD; Rushi V. Parikh, MD; Asim M. Rafique, MD
Download
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial Spyridon G. Deftereos, MD, PhD; Georgios Giannopoulos, MD, PhD; Dimitrios A. Vrachatis, MD, MSc, PhD;...
Download
Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)—An Old Drug With New Life? Amir B. Rabbani, MD; Rushi V. Parikh, MD; Asim M. Rafique, MD
Download